In the midst of tighter state and federal regulations on opioids, it is increasingly difficult for physicians to accurately assess a patient's condition in the time allotted, according to a physician editorial in The Huffington Post.
The Latest
A Johns Hopkins study published in the Annals of Internal Medicine reveals that the genetically engineered drug etanercept falls short in effectiveness compared to the current standard of care for steroid injections.
Results from a new study conducted by neurological and orthopedic surgeons at the University of California, San Francisco Medical Center suggests there may be problems with how hospital readmissions rates are reported.
Spine device company SI-BONE has named Michael Mydra vice president of health outcomes and reimbursement.
Stryker reported first quarter net sales at $2.2 billion, a 7.2 percent increase over the first period of 2011.
OMNIlife science, a medical device company based in Massachusetts, recently received two patents related to the company's computer- and robotic-assisted surgery platform for knee procedures.
UPMC Sports Medicine has expanded its concussion program, which includes nine examination rooms for a 24-person multispecialty staff devoted to assessing, treating, managing and researching concussions.
Researchers recently compared monopolar capacitive coupled with radiofrequency and platelet-rich plasma injection therapy, showing the two were similarly effective treatments for orthopedic conditions, according to a Medscape Today report.
Researchers recently compared monopolar capacitive coupled with radiofrequency and platelet-rich plasma injection therapy, showing the two were similarly effective treatments for orthopedic conditions, according to a Medscape Today report.
Orthopedic surgeons' loyalty to certain device companies has significant repercussions on a hospital's bottom line, vendor consolidation efforts and physician employment strategies.